EUVIMEDEUVIMED entdecken
Crossref

Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1

Hannes O Tiedt, Beate Benjamin, Michael Niedeggen, Andreas Lueschow

Neurodegenerative Diseases · 2018 · 18 (2-3) · 57-68

DOI: 10.1159/000485899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurodegenerative Diseases, online erschienen am 22.02.2018. Verfasst von Hannes O Tiedt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin (CBF), Berlin, Germany. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In rare cases, patients with Alzheimer disease (AD) present at an early age and with a family history suggestive of an autosomal dominant mode of inheritance. Mutations of the presenilin-1 (PSEN1) gene are the most common causes of dementia in these patients. Early-onset and particularly familial AD patients frequently present with variable non-amnestic cognitive symptoms such as visual, language or behavioural changes as well as non-cognitive, e.g. motor, symptoms.

Objective

To investigate the phenotypic variability in carriers of the PSEN1 S170F mutation.

Methods

We report a family with 4 patients carrying the S170F mutation of whom 2 underwent detailed clinical examinations. We discuss our current findings in the context of previously reported S170F cases.

Results

The clinical phenotype was consistent regarding initial memory impairment and early onset in the late twenties found in all S170F patients. There were frequent non-amnestic cognitive changes and, at early stages of the disease, indications of a more pronounced disturbance of visuospatial abilities as compared to face and object recognition. Non-cognitive symptoms most often included myoclonus and cerebellar ataxia. A review of the available case reports indicates some phenotypic variability associated with the S170F mutation including different constellations of symptoms such as parkinsonism and delusions.

Conclusion

The variable clinical findings associated with the S170F mutation highlight the relevance of atypical phenotypes in the context of research and under a clinical perspective. CSF sampling and detection of Aβ species may be essential to indicate AD pathology in unclear cases presenting with cognitive and motor symptoms at a younger age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-Protein PrecursorBiological Variation, PopulationHeterozygoteHumansMaleMemory DisordersMiddle AgedMutationPhenotypePresenilin-1

Stichwörter der Autor:innen

Alzheimer diseaseCerebellar ataxiaEarly-onset Alzheimer diseaseFamilial Alzheimer diseaseHereditary diseasesNeurodegenerative diseaseNeuropsychologyPSEN1 protein, humanPresenilin-1

Substanzen

Amyloid beta-Protein PrecursorPresenilin-1

Autor:innen und Institutionen

  • Department of Neurology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin (CBF), Berlin, Germany.

Zitieren

APA

Tiedt, H. O., Benjamin, B., Niedeggen, M., & Lueschow, A. (2018). Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1. Neurodegenerative Diseases, 18(2-3), 57-68. https://doi.org/10.1159/000485899

Vancouver

Tiedt HO, Benjamin B, Niedeggen M, Lueschow A. Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1. Neurodegenerative Diseases. 2018;18(2-3):57-68. doi:10.1159/000485899

BibTeX
@article{Tiedt2018,
  author = {Tiedt, Hannes O and Benjamin, Beate and Niedeggen, Michael and Lueschow, Andreas},
  title = {Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1},
  journal = {Neurodegenerative Diseases},
  year = {2018},
  volume = {18},
  number = {2-3},
  pages = {57--68},
  doi = {10.1159/000485899}
}
Kostenlos starten →